Cipherome

Executive Summary

Cipherome, founded in 2015 and headquartered in San Diego, offers the COMPASS Data Analysis Platform, an end-to-end solution designed to accelerate genomic and diagnostic data analysis. The platform eliminates the need for manual scripting in Python or R, enabling researchers to derive insights from complex datasets within minutes. By targeting the growing genomics and diagnostics sectors, Cipherome addresses a critical bottleneck in data interpretation, which is essential for precision medicine and clinical decision-making. While the company lacks publicly disclosed funding, valuation, or clinical pipelines, its focus on streamlining bioinformatics workflows positions it as a potential enabler for labs and biotech firms seeking to scale genomic analysis without dedicated computational expertise.

Upcoming Catalysts (preview)

• Q3 2026Strategic partnership with major genomic testing labs40% success
• Q4 2026Release of AI-powered predictive analytics module50% success
• H2 2026Series A funding announcement30% success